US pharma giant Merck & Co opened Tuesday’s trading 10% lower after announcing its annual and fourth quarter financial ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease. 1 Because it is also one of the few cancers that can be largely prevented ...

Now, he is calling for everyone to come forwards for their 'lifesaving' HPV vaccine. Cancers that affect ... into the swollen lymph node a fine needle to withdraw some fluid to check for any ...

COVID-19 Phase 2b study poised to initiate 10,000 participant portion of trial pending U.S. Food and Drug Administration (FDA) review of sentinel ...

Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick ... papillomavirus (HPV), Vaxart’s first ...

"On behalf of Vaxart and its Board, I would like to thank Bob for his years of service and contributions to our Company,” said Vaxart Board Chairman, Dr. Michael J. Finney.

Independent Data Safety Monitoring Board (DSMB) recommends study to proceed without modifications based on initial safety assessment of 400 participant 30-day data The company plans to progress the ...